You are here

Procrit

Pfizer launches biosimilar version of Amgen's Epogen

Biopharma Dive

Wed, 11/14/18 - 11:45 pm

FDA panel backs Pfizer biosim to blockbuster anemia meds from Amgen, Johnson & Johnson

Fierce Pharma

Mon, 05/29/17 - 12:00 pm

advisory panels

Some cancer docs still bill heavily for Amgen's Epogen despite safety questions

Fierce Pharma

Mon, 06/23/14 - 12:53 pm

Is Johnson & Johnson Heading Off The Patent Cliff?

Seeking Alpha

Mon, 05/13/13 - 09:12 am

EPO Pills: A Challenge For Amgen And Johnson & Johnson

Seeking Alpha

Thu, 05/2/13 - 03:50 pm

FDA recommends lower doses of anemia drugs

Yahoo/AP

Sat, 06/25/11 - 10:37 am

chronic kidney disease

Amgen, J&J Anemia Drugs Won’t Face New U.S. Coverage Policy

Bloomberg

Thu, 06/16/11 - 10:14 pm

Amgen’s Epogen, J&J’s Procrit Boost Heart Attack Patients’ Risk

Bloomberg

Wed, 05/11/11 - 08:47 am

Analysts say current Medicare policy on anemia drugs is best scenario for Amgen

Yahoo/AP

Thu, 03/17/11 - 06:21 pm

Amgen Rises On Medicare’s Decision Not To Decide

Forbes

Wed, 03/16/11 - 09:52 pm

FDA may limit anemia drug use for kidney disease

Yahoo/AP

Thu, 10/14/10 - 11:03 am

Amgen recalls anemia drugs due to glass flakes

Yahoo/AP

Fri, 09/24/10 - 11:14 am

J&J on Hook for "Hundreds of Millions" Over Technicality in Anemia Drug Case

BNET Pharma

Tue, 06/22/10 - 02:49 pm

Medicare mulls new restrictions on anemia meds

Fierce Pharma

Fri, 06/18/10 - 07:52 am

FDA asks Amgen, J&J to discuss anemia drug risks

Yahoo/AP

Tue, 02/16/10 - 10:24 am

Amgen’s, J&J’s Anemia Drugs Face FDA Advisory Review on Dose

Bloomberg

Thu, 01/7/10 - 09:53 am

Study confirms clot risks with anti-anemia drugs

Reuters

Wed, 11/11/09 - 08:21 am

Drug Rep in $3B Procrit Case: "80% of My Sales Were Medicare Fraud"; Carried $400K in "Cash"

BNET Pharma

Mon, 08/17/09 - 07:53 pm